Nutritional status of patients with cystic fibrosis with meconium ileus: Acomparison with patients without meconium ileus and diagnosed early through neonatal screening
Hc. Lai et al., Nutritional status of patients with cystic fibrosis with meconium ileus: Acomparison with patients without meconium ileus and diagnosed early through neonatal screening, PEDIATRICS, 105(1), 2000, pp. 53-61
Objective. This study was pursued as an extension of a randomized clinical
investigation of neonatal screening for cystic fibrosis (CF). The objective
was to determine if CF patients with meconium ileus (MI) were more likely
to be malnourished compared with those without MI who were diagnosed during
early infancy through neonatal screening.
Methodology. Nutritional status was evaluated from early infancy to 13 year
s of age based on anthropometric, biochemical, and dietary assessments.
Results. MI patients (n = 32) were smaller at birth (3117 g compared with 3
413 g) and were shorter (22nd percentile compared with 48th percentile) and
thinner (24th percentile compared with 49th percentile) compared with non-
MI early diagnosed patients (n = 50) up to 13 years of age. Poor growth was
particularly evident in 26 MI patients who required surgery for MI (height
and weight at the 20th percentile), whereas those treated without surgery
(n = 6) showed better height (45th percentile) and weight (37th percentile)
. Abnormal essential fatty acid profiles were significantly more prevalent
in MI compared with non-MI early-diagnosed patients before 3 years of age.
Daily intakes of calorie (130% compared with 111% recommended dietary allow
ances) and protein (339% compared with 279% recommended dietary allowances)
were higher but the percentage of fat (37% compared with 38%) and linoleic
acid (4.5% compared with 4.7%) in the diet were similar between the two gr
oups.
Conclusions. These results demonstrated a clear association of MI with maln
utrition in CF. The observed poor growth among our MI patients was not beca
use of poor dietary intakes, but was related to surgical treatment for MI a
nd poor essential fatty acid status. These findings present new challenges
regarding the optimal medical treatment and nutritional intervention for CF
patients with MI.